Table 1 Application of magnetic targeting techniques in pre-clinical studies
From: Magnetic targeting as a strategy to enhance therapeutic effects of mesenchymal stromal cells
Target | MSC donor | MSC recipient | Nanoparticle | Magnetic device | Magnetic device position | Reference |
|---|---|---|---|---|---|---|
Knee joint (cartilage) | Human | Pigs and rabbits | Feridex (Tanabe Seiyaku) | Electromagnet | External | [10] |
Rabbit | Rabbits | Ferucarbotran/Resovist® | Permanent magnet | External | [24] | |
Meniscus | Rabbit | Rabbit | Ferucarbotran/Resovist® | Permanent magnet | External | [25] |
Skeletal muscle | Human | Rats | Risovist® | Electromagnet | External | [23] |
Bones | Rat | Rats | Ferucarbotran/Resovist® | Permanent magnet | External | [26] |
Spinal cord | Rat | Rats | Poly-l-lysine-coated SPIONs | Permanent magnet | Implanted | [21] |
Not reported | Rats | Not reported | Permanent magnet | External | [20] | |
Retina | Rat | Rats | FluidMAG-D® | Permanent magnet | Implanted | [27] |
Arteries | Rabbit | Rabbits | FluidMAG-D® | Permanent magnet | External | [29] |
Heart | Rat | Rats | Ferucarbotran/Resovist® | Permanent magnet | External | [49] |
Pig | Pigs | Gadolinium nanotubes and Molday ION(–)® | Permanent magnet | Implanted | [22] | |
Rat | Rats | Ferucarbotran/Resovist® | Permanent magnet | External | [11] | |
Lung | Human | Mouse | DMSA-coated maghemite nanoparticles | Permanent magnet | External | [33] |